CA2681718A1 - Hiv-1 protease inhibitors - Google Patents
Hiv-1 protease inhibitors Download PDFInfo
- Publication number
- CA2681718A1 CA2681718A1 CA002681718A CA2681718A CA2681718A1 CA 2681718 A1 CA2681718 A1 CA 2681718A1 CA 002681718 A CA002681718 A CA 002681718A CA 2681718 A CA2681718 A CA 2681718A CA 2681718 A1 CA2681718 A1 CA 2681718A1
- Authority
- CA
- Canada
- Prior art keywords
- alkyl
- compound
- heterocyclyl
- amino
- amido
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/24—Oxygen atoms attached in position 2 with hydrocarbon radicals, substituted by oxygen atoms, attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91981907P | 2007-03-23 | 2007-03-23 | |
US91989607P | 2007-03-23 | 2007-03-23 | |
US60/919,819 | 2007-03-23 | ||
US60/919,896 | 2007-03-23 | ||
US94178607P | 2007-06-04 | 2007-06-04 | |
US94182907P | 2007-06-04 | 2007-06-04 | |
US60/941,829 | 2007-06-04 | ||
US60/941,786 | 2007-06-04 | ||
PCT/US2008/058004 WO2008118849A2 (en) | 2007-03-23 | 2008-03-24 | Hiv-1 protease inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2681718A1 true CA2681718A1 (en) | 2008-10-02 |
Family
ID=39789249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002681718A Abandoned CA2681718A1 (en) | 2007-03-23 | 2008-03-24 | Hiv-1 protease inhibitors |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2139883A4 (de) |
CN (1) | CN101702908A (de) |
CA (1) | CA2681718A1 (de) |
WO (1) | WO2008118849A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010135424A1 (en) * | 2009-05-19 | 2010-11-25 | Glaxosmithkline Llc | Chemical compounds |
WO2011061590A1 (en) | 2009-11-17 | 2011-05-26 | Hetero Research Foundation | Novel carboxamide derivatives as hiv inhibitors |
CN109890808B (zh) | 2016-08-19 | 2020-08-07 | 吉利德科学公司 | 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物 |
JOP20180009A1 (ar) | 2017-02-06 | 2019-01-30 | Gilead Sciences Inc | مركبات مثبط فيروس hiv |
TWI687415B (zh) | 2017-08-17 | 2020-03-11 | 美商基利科學股份有限公司 | Hiv蛋白質膜抑制劑之固體形式 |
AR112412A1 (es) | 2017-08-17 | 2019-10-23 | Gilead Sciences Inc | Formas de sal de colina de un inhibidor de la cápside del vih |
CN108220482A (zh) * | 2018-02-11 | 2018-06-29 | 广西医科大学 | 艾滋病治疗药物NRTIs耐药突变位点G73S的引物及其应用 |
JP7083398B2 (ja) | 2018-02-15 | 2022-06-10 | ギリアード サイエンシーズ, インコーポレイテッド | ピリジン誘導体およびhiv感染を処置するためのその使用 |
KR20210033492A (ko) * | 2018-07-16 | 2021-03-26 | 길리애드 사이언시즈, 인코포레이티드 | Hiv의 치료를 위한 캡시드 억제제 |
TWI766172B (zh) | 2018-07-30 | 2022-06-01 | 美商基利科學股份有限公司 | 抗hiv化合物 |
EP3938371A4 (de) * | 2019-01-15 | 2023-01-18 | Purdue Research Foundation | Hiv-1-proteasehemmer und verwendungen davon |
WO2023102239A1 (en) | 2021-12-03 | 2023-06-08 | Gilead Sciences, Inc. | Therapeutic compounds for hiv virus infection |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040122000A1 (en) * | 1981-01-07 | 2004-06-24 | Vertex Pharmaceuticals Incorporated. | Inhibitors of aspartyl protease |
US5877334A (en) * | 1996-07-23 | 1999-03-02 | Abbott Laboratories | Intermediates useful in solid phase synthesis method |
WO1999067254A2 (en) * | 1998-06-23 | 1999-12-29 | The United States Of America Represented By The Secretary, Department Of Health And Human Services | Multi-drug resistant retroviral protease inhibitors and use thereof |
TNSN00027A1 (fr) * | 1999-02-12 | 2005-11-10 | Vertex Pharma | Inhibiteurs de l'aspartyle protease |
TWI286476B (en) * | 2001-12-12 | 2007-09-11 | Tibotec Pharm Ltd | Combination of cytochrome P450 dependent protease inhibitors |
WO2003091264A2 (en) * | 2002-04-26 | 2003-11-06 | Gilead Sciences, Inc. | Non nucleoside reverse transcriptase inhibitors |
US7462636B2 (en) * | 2002-05-17 | 2008-12-09 | Tibotec Pharmaceuticals Ltd | Broadspectrum substituted benzisoxazole sulfonamide HIV protease inhibitors |
US7807845B2 (en) * | 2004-03-11 | 2010-10-05 | Sequoia Pharmaceuticals, Inc. | Resistance-repellent retroviral protease inhibitors |
EP1855672A4 (de) * | 2005-03-11 | 2011-11-30 | Glaxosmithkline Llc | Hiv-proteasehemmer |
-
2008
- 2008-03-24 CN CN200880016701A patent/CN101702908A/zh active Pending
- 2008-03-24 CA CA002681718A patent/CA2681718A1/en not_active Abandoned
- 2008-03-24 EP EP08744245A patent/EP2139883A4/de not_active Withdrawn
- 2008-03-24 WO PCT/US2008/058004 patent/WO2008118849A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2008118849A3 (en) | 2008-12-18 |
WO2008118849A2 (en) | 2008-10-02 |
CN101702908A (zh) | 2010-05-05 |
EP2139883A4 (de) | 2011-06-22 |
EP2139883A2 (de) | 2010-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2681718A1 (en) | Hiv-1 protease inhibitors | |
US8933075B2 (en) | Compounds useful as antiviral agents, compositions, and methods of use | |
CA2658545A1 (en) | Bisfuranyl protease inhibitors | |
US20110178092A1 (en) | HIV-1 Protease Inhibitors | |
AU2002302363B2 (en) | Broadspectrum 2-(substituted-amino)-benzothiazole sulfonamide HIV protease inhibitors | |
TWI385173B (zh) | 作為hiv蛋白酶抑制劑之經取代的胺基苯基磺醯胺化合物 | |
CA2667445A1 (en) | Hiv-1 protease inhibitors | |
AU2003262561B2 (en) | Broadspectrum 2-amino-benzothiazole sulfonamide HIV protease inhibitors | |
AU2002361235B2 (en) | Broadspectrum heterocyclic substituted phenyl containing sulfonamide HIV protease inhibitors | |
CA2485903C (en) | Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors | |
US7148243B2 (en) | Antivirals | |
EP2196453A1 (de) | Neuartige substituierte Aryl-Derivate, Herstellungsverfahren dafür und ihre therapeutische Verwendungen als anti-HIV-Mittel | |
CA2667449A1 (en) | Hiv-1 protease inhibitors, and methods of making and using them | |
AU2009301131B2 (en) | New amide compounds as boosters of antivirals | |
EP1960381B1 (de) | Aminophenylsulphonamidderivate als inhibitoren der hiv-protease | |
IL163960A (en) | Benzimidazoles Sulphonamides are broad-spectrum as vih protease inhibitors and as an overall preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Discontinued |